Pauwels Eric
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Pauwels Eric. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PTCT | CHIEF BUSINESS OFFICER | Sale | 1,500 | $75.77 | $113,655 | Dec 19, 2025 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 35,261 | $75.44 | $2,660,090 | Dec 17, 2025 |
| PTCT | CHIEF BUSINESS OFFICER | Option Exercise | 6,017 | $11.23 | $67,571 | Sep 8, 2025 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 1,085 | $56.62 | $61,433 | Mar 17, 2025 |
| PTCT | CHIEF EXECUTIVE OFFICER | Sale | 1,378 | $50.10 | $69,038 | Feb 20, 2025 |
| PTCT | CHIEF EXECUTIVE OFFICER | Sale | 1,599 | $45.34 | $72,499 | Jan 8, 2025 |
| PTCT | CHIEF EXECUTIVE OFFICER | Award / Grant | 22,000 | — | — | Jan 3, 2025 |
| PTCT | CHIEF EXECUTIVE OFFICER | Sale | 787 | $25.14 | $19,785 | Apr 17, 2024 |
| PTCT | CHIEF BUSINESS OFFICER | Award / Grant | 22,000 | — | — | Feb 15, 2024 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 366 | $27.25 | $9,974 | Jan 30, 2024 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 2,065 | $29.01 | $59,906 | Jan 8, 2024 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 100 | $59.66 | $5,966 | May 22, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 800 | $58.52 | $46,816 | May 17, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 732 | $52.04 | $38,093 | Apr 18, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 375 | $45.63 | $17,111 | Jan 31, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 359 | $47.45 | $17,035 | Jan 24, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 571 | $44.36 | $25,330 | Jan 10, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 858 | $41.66 | $35,744 | Jan 9, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Award / Grant | 18,000 | — | — | Jan 5, 2023 |
| PTCT | CHIEF BUSINESS OFFICER | Sale | 822 | $42.52 | $34,951 | Apr 19, 2022 |
| PTCT | Chief Business Officer | Sale | 367 | $40.00 | $14,680 | Feb 1, 2022 |
| PTCT | Chief Business Officer | Sale | 359 | $39.31 | $14,112 | Jan 25, 2022 |
| PTCT | Chief Business Officer | Sale | 866 | $38.53 | $33,367 | Jan 7, 2022 |
| PTCT | Chief Business Officer | Sale | 806 | $41.16 | $33,175 | Jan 4, 2022 |
| PTCT | Chief Business Officer | Sale | 786 | $48.17 | $37,862 | Apr 19, 2021 |
| PTCT | Chief Business Officer | Sale | 362 | $56.96 | $20,620 | Feb 1, 2021 |
| PTCT | Chief Business Officer | Sale | 431 | $62.05 | $26,744 | Jan 25, 2021 |
| PTCT | Chief Business Officer | Award / Grant | 10,200 | — | — | Jan 6, 2021 |
| PTCT | Chief Business Officer | Sale | 289 | $62.37 | $18,025 | Jan 5, 2021 |
| PTCT | Chief Business Officer | Sale | 6,194 | $56.50 | $349,961 | Nov 3, 2020 |
| PTCT | Chief Business Officer | Award / Grant | 10,000 | — | — | Apr 16, 2020 |
| 0000890465 | President, NPS Pharma Int'l | U | 30,029 | $46.00 | $1,381,334 | Feb 21, 2015 |
| 0000890465 | President, NPS Pharma Int'l | Tax Withholding | 3,005 | $45.88 | $137,869 | Feb 7, 2015 |
| 0000890465 | President, NPS Pharma Int'l | Other | 10,000 | — | — | Sep 26, 2014 |
| 0000890465 | President, NPS Pharma Int'l | Tax Withholding | 620 | $27.86 | $17,273 | Aug 1, 2014 |
| 0000890465 | SVP & Chief Commercial Officer | Option Exercise | 8,100 | — | — | Feb 13, 2014 |
| 0000890465 | SVP & Chief Commercial Officer | Tax Withholding | 1,759 | $35.13 | $61,794 | Feb 7, 2014 |
| 0000890465 | SVP & Chief Commercial Officer | Other | 4,866 | — | — | Feb 7, 2013 |
| 0000890465 | SVP & Chief Commercial Officer | Award / Grant | 14,600 | — | — | Feb 7, 2012 |
| 0000890465 | Chief Commercial Officer | Award / Grant | 10,000 | — | — | Sep 26, 2011 |
| ARAY | SVP Chief Marketing Officer | Award / Grant | 30,000 | — | — | Feb 28, 2011 |